Title | Type | SJR | H index | Total Docs. (2022) | Total Docs. (3years) | Total Refs. (2022) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2022) | %Female (2022) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Frontiers in Oncology | journal | 1.138 Q2 | 136 | 7532 | 10156 | 397912 | 49128 | 10000 | 4.45 | 52.83 | 42.10 | |
2 | Cancers | journal | 1.312 Q2 | 133 | 6215 | 12215 | 464490 | 66962 | 11977 | 5.11 | 74.74 | 44.08 | |
3 | BMC Cancer | journal | 1.137 Q2 | 160 | 1343 | 3770 | 54250 | 16278 | 3769 | 3.75 | 40.39 | 41.21 | |
4 | Cell Death and Disease | journal | 2.188 Q1 | 164 | 1028 | 3018 | 54585 | 27098 | 2982 | 8.33 | 53.10 | 43.98 | |
5 | European Journal of Cancer | journal | 2.898 Q1 | 245 | 806 | 1353 | 15906 | 9370 | 1084 | 6.24 | 19.73 | 42.57 | |
6 | Anticancer Research | journal | 0.591 Q3 | 136 | 677 | 2375 | 22754 | 5416 | 2373 | 2.07 | 33.61 | 25.78 | |
7 | Journal for ImmunoTherapy of Cancer | journal | 3.403 Q1 | 117 | 531 | 1395 | 22237 | 14506 | 1384 | 9.00 | 41.88 | 42.18 | |
8 | Cell Death Discovery | journal | 1.545 Q1 | 58 | 484 | 594 | 23950 | 3845 | 576 | 6.53 | 49.48 | 43.01 | |
9 | Leukemia and Lymphoma | journal | 0.837 Q3 | 102 | 475 | 1552 | 13932 | 2581 | 938 | 1.65 | 29.33 | 43.14 | |
10 | Oral Oncology | journal | 1.271 Q2 | 137 | 467 | 1194 | 10387 | 4006 | 748 | 2.96 | 22.24 | 35.90 | |
11 | Oncology Letters | journal | 0.657 Q3 | 81 | 460 | 3487 | 21237 | 10354 | 3486 | 2.81 | 46.17 | 36.61 | |
12 | Cancer Medicine | journal | 1.188 Q2 | 84 | 442 | 2390 | 18227 | 10563 | 2384 | 3.90 | 41.24 | 41.25 | |
13 | Oncogene | journal | 2.311 Q1 | 370 | 434 | 1506 | 22573 | 11585 | 1497 | 7.33 | 52.01 | 42.32 | |
14 | British Journal of Cancer | journal | 2.867 Q1 | 272 | 427 | 1193 | 21351 | 9632 | 1036 | 7.71 | 50.00 | 41.74 | |
15 | Cancer Cell International | journal | 1.145 Q2 | 80 | 408 | 1569 | 28061 | 8859 | 1567 | 5.52 | 68.78 | 43.15 | |
16 | Future Oncology | journal | 0.874 Q2 | 90 | 404 | 1149 | 16286 | 3380 | 1078 | 2.88 | 40.31 | 40.62 | |
17 | Signal Transduction and Targeted Therapy | journal | 6.630 Q1 | 117 | 389 | 778 | 39771 | 14754 | 479 | 19.08 | 102.24 | 42.94 | |
18 | In Vivo | journal | 0.540 Q3 | 72 | 378 | 1239 | 12438 | 2990 | 1239 | 2.39 | 32.90 | 30.57 | |
19 | Cancer Letters | journal | 2.088 Q1 | 216 | 376 | 1321 | 25485 | 11923 | 1303 | 9.11 | 67.78 | 41.13 | |
20 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.285 Q4 | 56 | 371 | 1334 | 17903 | 2072 | 693 | 1.82 | 48.26 | 43.90 | |
21 | Molecular Medicine Reports | journal | 0.711 Q3 | 86 | 363 | 2816 | 16713 | 9976 | 2816 | 3.36 | 46.04 | 43.30 | |
22 | Leukemia | journal | 3.376 Q1 | 219 | 339 | 1097 | 13265 | 8491 | 895 | 7.64 | 39.13 | 43.48 | |
23 | Journal of Experimental and Clinical Cancer Research | journal | 2.413 Q1 | 120 | 330 | 1058 | 21141 | 11401 | 1056 | 9.37 | 64.06 | 44.91 | |
24 | Journal of Cancer Research and Clinical Oncology | journal | 1.017 Q2 | 109 | 304 | 923 | 12788 | 3834 | 892 | 3.81 | 42.07 | 39.12 | |
25 | Journal of Neuro-Oncology | journal | 1.178 Q2 | 135 | 294 | 835 | 11690 | 3523 | 808 | 3.87 | 39.76 | 34.77 | |
26 | Journal of the National Cancer Institute | journal | 5.409 Q1 | 387 | 262 | 654 | 9150 | 5072 | 461 | 7.02 | 34.92 | 48.38 | |
27 | Neuro-Oncology | journal | 4.833 Q1 | 163 | 260 | 714 | 8931 | 7060 | 450 | 9.68 | 34.35 | 40.76 | |
28 | ESMO Open | journal | 2.196 Q1 | 60 | 252 | 582 | 8577 | 3350 | 502 | 5.80 | 34.04 | 40.25 | |
29 | Cancer Reports | journal | 0.513 Q4 | 18 | 241 | 245 | 8110 | 509 | 239 | 2.06 | 33.65 | 39.62 | |
30 | Cancer Immunology, Immunotherapy | journal | 1.663 Q1 | 136 | 239 | 698 | 10323 | 4302 | 680 | 5.85 | 43.19 | 35.61 | |
31 | Molecular Oncology | journal | 1.778 Q1 | 113 | 232 | 601 | 15586 | 4099 | 586 | 6.79 | 67.18 | 46.18 | |
32 | Virus Research | journal | 1.034 Q2 | 144 | 228 | 772 | 11910 | 3814 | 767 | 5.44 | 52.24 | 43.42 | |
33 | Clinical and Translational Oncology | journal | 0.831 Q3 | 61 | 224 | 725 | 11618 | 2455 | 695 | 3.40 | 51.87 | 45.80 | |
34 | Lung Cancer | journal | 1.609 Q1 | 148 | 221 | 992 | 8398 | 4876 | 875 | 4.45 | 38.00 | 39.56 | |
35 | Oncology Reports | journal | 0.837 Q3 | 115 | 210 | 1364 | 8984 | 5346 | 1364 | 3.89 | 42.78 | 36.04 | |
36 | Molecular Cancer | journal | 8.703 Q1 | 196 | 208 | 475 | 17628 | 16683 | 427 | 28.64 | 84.75 | 40.29 | |
37 | Japanese Journal of Clinical Oncology | journal | 0.743 Q3 | 95 | 202 | 669 | 5293 | 1628 | 595 | 2.05 | 26.20 | 18.90 | |
38 | Cancer Epidemiology | journal | 1.113 Q2 | 86 | 190 | 474 | 7430 | 1467 | 453 | 2.58 | 39.11 | 50.12 | |
39 | Bulletin du Cancer | journal | 0.336 Q4 | 44 | 178 | 590 | 5172 | 569 | 438 | 0.87 | 29.06 | 49.86 | |
40 | Cancer Gene Therapy | journal | 1.384 Q2 | 99 | 178 | 231 | 8770 | 1418 | 222 | 6.38 | 49.27 | 40.49 | |
41 | Journal of Hematology and Oncology | journal | 6.046 Q1 | 144 | 169 | 497 | 18270 | 11261 | 433 | 20.94 | 108.11 | 41.80 | |
42 | Human Cell | journal | 0.773 Q3 | 44 | 164 | 372 | 7423 | 1465 | 347 | 3.95 | 45.26 | 38.90 | |
43 | International Journal of Hyperthermia | journal | 0.762 Q3 | 98 | 160 | 561 | 6613 | 1969 | 541 | 3.07 | 41.33 | 37.38 | |
44 | ecancermedicalscience | journal | 0.665 Q3 | 47 | 159 | 473 | 6498 | 1111 | 470 | 1.93 | 40.87 | 43.84 | |
45 | Molecular and Clinical Oncology | journal | 0.393 Q4 | 19 | 156 | 605 | 5238 | 915 | 604 | 1.29 | 33.58 | 26.80 | |
46 | Molecular Therapy - Oncolytics | journal | 1.339 Q2 | 42 | 154 | 420 | 9805 | 2379 | 420 | 5.60 | 63.67 | 40.14 | |
47 | Cancer Treatment and Research Communications | journal | 0.674 Q3 | 23 | 152 | 357 | 6582 | 933 | 338 | 2.57 | 43.30 | 44.63 | |
48 | International Journal of Oncology | journal | 1.116 Q2 | 139 | 152 | 661 | 10174 | 3674 | 660 | 4.90 | 66.93 | 38.69 | |
49 | Discover Oncology | journal | 0.514 Q4 | 44 | 142 | 107 | 7354 | 277 | 103 | 2.24 | 51.79 | 43.01 | |
50 | Pathology and Oncology Research | journal | 0.640 Q3 | 61 | 140 | 694 | 5769 | 1759 | 640 | 2.63 | 41.21 | 42.66 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®